instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Drug interaction'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Recovered | ReactionOutcome | CC BY | 33964989 | 19,370,998 | 2021-05-09 |
What was the outcome of reaction 'Somnolence'? | Flumazenil therapy for a gabapentin-induced coma: a case report.
BACKGROUND
Spasticity and neuropathic pain are common in patients after spinal cord injury and negatively affect patients' quality of life. Gabapentin and baclofen are frequently used to treat these conditions. We present a flumazenil-reversed gabapentin-... | Recovered | ReactionOutcome | CC BY | 33964989 | 19,326,314 | 2021-05-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment noncompliance'. | Recurrent Colon Cancer: Presentation With Disseminated Intravascular Coagulation From Disseminated Carcinomatosis of the Bone Marrow.
Diffuse carcinomatosis of the bone marrow (DCBM) is a rare clinical condition characterized by diffuse bone marrow involvement with hematological changes. This case study concerns a pati... | FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33966469 | 19,560,416 | 2021 |
What was the dosage of drug 'FLUOROURACIL'? | Recurrent Colon Cancer: Presentation With Disseminated Intravascular Coagulation From Disseminated Carcinomatosis of the Bone Marrow.
Diffuse carcinomatosis of the bone marrow (DCBM) is a rare clinical condition characterized by diffuse bone marrow involvement with hematological changes. This case study concerns a pati... | UNKNOWN | DrugDosageText | CC BY-NC | 33966469 | 19,560,416 | 2021 |
What was the dosage of drug 'LEUCOVORIN'? | Recurrent Colon Cancer: Presentation With Disseminated Intravascular Coagulation From Disseminated Carcinomatosis of the Bone Marrow.
Diffuse carcinomatosis of the bone marrow (DCBM) is a rare clinical condition characterized by diffuse bone marrow involvement with hematological changes. This case study concerns a pati... | UNKNOWN | DrugDosageText | CC BY-NC | 33966469 | 19,560,416 | 2021 |
What was the dosage of drug 'OXALIPLATIN'? | Recurrent Colon Cancer: Presentation With Disseminated Intravascular Coagulation From Disseminated Carcinomatosis of the Bone Marrow.
Diffuse carcinomatosis of the bone marrow (DCBM) is a rare clinical condition characterized by diffuse bone marrow involvement with hematological changes. This case study concerns a pati... | UNKNOWN | DrugDosageText | CC BY-NC | 33966469 | 19,560,416 | 2021 |
What was the outcome of reaction 'Treatment noncompliance'? | Recurrent Colon Cancer: Presentation With Disseminated Intravascular Coagulation From Disseminated Carcinomatosis of the Bone Marrow.
Diffuse carcinomatosis of the bone marrow (DCBM) is a rare clinical condition characterized by diffuse bone marrow involvement with hematological changes. This case study concerns a pati... | Fatal | ReactionOutcome | CC BY-NC | 33966469 | 19,560,416 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | A Rare Case of Double Antibody-Positive Rapidly Progressive Glomerulonephritis: A Therapeutic Challenge.
Crescentic glomerulonephritis, also known as rapidly progressive glomerulonephritis, is a syndrome characterized by progressive and rapid deterioration of renal function over the course of weeks to months. Oliguria,... | AMLODIPINE BESYLATE, CYCLOPHOSPHAMIDE, HYDROCHLOROTHIAZIDE\LOSARTAN, LEVOTHYROXINE, PREDNISONE, RITUXIMAB, SIMVASTATIN, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC | 33966476 | 20,320,118 | 2021 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | A Rare Case of Double Antibody-Positive Rapidly Progressive Glomerulonephritis: A Therapeutic Challenge.
Crescentic glomerulonephritis, also known as rapidly progressive glomerulonephritis, is a syndrome characterized by progressive and rapid deterioration of renal function over the course of weeks to months. Oliguria,... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33966476 | 20,320,118 | 2021 |
What was the administration route of drug 'RITUXIMAB'? | A Rare Case of Double Antibody-Positive Rapidly Progressive Glomerulonephritis: A Therapeutic Challenge.
Crescentic glomerulonephritis, also known as rapidly progressive glomerulonephritis, is a syndrome characterized by progressive and rapid deterioration of renal function over the course of weeks to months. Oliguria,... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33966476 | 20,320,118 | 2021 |
What was the dosage of drug 'AMLODIPINE BESYLATE'? | A Rare Case of Double Antibody-Positive Rapidly Progressive Glomerulonephritis: A Therapeutic Challenge.
Crescentic glomerulonephritis, also known as rapidly progressive glomerulonephritis, is a syndrome characterized by progressive and rapid deterioration of renal function over the course of weeks to months. Oliguria,... | AMLODIPINE 10 MG DAILY | DrugDosageText | CC BY-NC | 33966476 | 20,320,118 | 2021 |
What was the dosage of drug 'HYDROCHLOROTHIAZIDE\LOSARTAN'? | A Rare Case of Double Antibody-Positive Rapidly Progressive Glomerulonephritis: A Therapeutic Challenge.
Crescentic glomerulonephritis, also known as rapidly progressive glomerulonephritis, is a syndrome characterized by progressive and rapid deterioration of renal function over the course of weeks to months. Oliguria,... | 50 TO 12.5 MG DAILY, | DrugDosageText | CC BY-NC | 33966476 | 20,320,118 | 2021 |
What was the dosage of drug 'LEVOTHYROXINE'? | A Rare Case of Double Antibody-Positive Rapidly Progressive Glomerulonephritis: A Therapeutic Challenge.
Crescentic glomerulonephritis, also known as rapidly progressive glomerulonephritis, is a syndrome characterized by progressive and rapid deterioration of renal function over the course of weeks to months. Oliguria,... | 125 MICROG DAILY | DrugDosageText | CC BY-NC | 33966476 | 20,320,118 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug-induced liver injury'. | Severe Liver Injury Associated With High-Dose Atorvastatin Therapy.
Statins are recommended for first-line management of elevated cholesterol in the primary and secondary prevention of atherosclerotic cardiovascular disease. Statins may occasionally be associated with mild transaminase elevations but can also result in... | ATORVASTATIN, GABAPENTIN, GLIPIZIDE, LISINOPRIL, METFORMIN HYDROCHLORIDE, OMEPRAZOLE, PAROXETINE, PIOGLITAZONE, TRAZODONE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33966478 | 19,431,827 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment noncompliance'. | Severe Liver Injury Associated With High-Dose Atorvastatin Therapy.
Statins are recommended for first-line management of elevated cholesterol in the primary and secondary prevention of atherosclerotic cardiovascular disease. Statins may occasionally be associated with mild transaminase elevations but can also result in... | SIMVASTATIN | DrugsGivenReaction | CC BY-NC | 33966478 | 19,910,203 | 2021 |
What was the administration route of drug 'SIMVASTATIN'? | Severe Liver Injury Associated With High-Dose Atorvastatin Therapy.
Statins are recommended for first-line management of elevated cholesterol in the primary and secondary prevention of atherosclerotic cardiovascular disease. Statins may occasionally be associated with mild transaminase elevations but can also result in... | Oral | DrugAdministrationRoute | CC BY-NC | 33966478 | 19,910,203 | 2021 |
What was the outcome of reaction 'Drug-induced liver injury'? | Severe Liver Injury Associated With High-Dose Atorvastatin Therapy.
Statins are recommended for first-line management of elevated cholesterol in the primary and secondary prevention of atherosclerotic cardiovascular disease. Statins may occasionally be associated with mild transaminase elevations but can also result in... | Recovered | ReactionOutcome | CC BY-NC | 33966478 | 19,431,827 | 2021 |
What was the outcome of reaction 'Liver injury'? | Severe Liver Injury Associated With High-Dose Atorvastatin Therapy.
Statins are recommended for first-line management of elevated cholesterol in the primary and secondary prevention of atherosclerotic cardiovascular disease. Statins may occasionally be associated with mild transaminase elevations but can also result in... | Recovered | ReactionOutcome | CC BY-NC | 33966478 | 19,364,799 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute promyelocytic leukaemia'. | Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid - no clear evidence of positive disease modifying effects.
BACKGROUND
All-trans retinoic acid (ATRA) is an acid derivative of vitamin A which is discussed as a promising candidate to ameliorate the disease course of multiple sclerosis (M... | AZATHIOPRINE, CYTARABINE, IDARUBICIN, INTERFERON BETA-1B, MERCAPTOPURINE, METHOTREXATE, METHYLPREDNISOLONE, MITOXANTRONE HYDROCHLORIDE, TRETINOIN | DrugsGivenReaction | CC BY | 33966627 | 19,904,224 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid - no clear evidence of positive disease modifying effects.
BACKGROUND
All-trans retinoic acid (ATRA) is an acid derivative of vitamin A which is discussed as a promising candidate to ameliorate the disease course of multiple sclerosis (M... | FINGOLIMOD, GLATIRAMER ACETATE, METHYLPREDNISOLONE, TERIFLUNOMIDE, TRETINOIN | DrugsGivenReaction | CC BY | 33966627 | 19,924,477 | 2021-05-10 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid - no clear evidence of positive disease modifying effects.
BACKGROUND
All-trans retinoic acid (ATRA) is an acid derivative of vitamin A which is discussed as a promising candidate to ameliorate the disease course of multiple sclerosis (M... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33966627 | 19,924,477 | 2021-05-10 |
What was the administration route of drug 'MITOXANTRONE HYDROCHLORIDE'? | Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid - no clear evidence of positive disease modifying effects.
BACKGROUND
All-trans retinoic acid (ATRA) is an acid derivative of vitamin A which is discussed as a promising candidate to ameliorate the disease course of multiple sclerosis (M... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33966627 | 19,904,224 | 2021-05-10 |
What was the administration route of drug 'TRETINOIN'? | Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid - no clear evidence of positive disease modifying effects.
BACKGROUND
All-trans retinoic acid (ATRA) is an acid derivative of vitamin A which is discussed as a promising candidate to ameliorate the disease course of multiple sclerosis (M... | Oral | DrugAdministrationRoute | CC BY | 33966627 | 19,924,477 | 2021-05-10 |
What was the dosage of drug 'CYTARABINE'? | Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid - no clear evidence of positive disease modifying effects.
BACKGROUND
All-trans retinoic acid (ATRA) is an acid derivative of vitamin A which is discussed as a promising candidate to ameliorate the disease course of multiple sclerosis (M... | 100 MILLIGRAM/SQ. METER, QD, ON DAY 1 | DrugDosageText | CC BY | 33966627 | 19,904,224 | 2021-05-10 |
What was the dosage of drug 'IDARUBICIN'? | Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid - no clear evidence of positive disease modifying effects.
BACKGROUND
All-trans retinoic acid (ATRA) is an acid derivative of vitamin A which is discussed as a promising candidate to ameliorate the disease course of multiple sclerosis (M... | 12 MILLIGRAM/SQ. METER, ON DAY 2, 4, 6, 8 | DrugDosageText | CC BY | 33966627 | 19,904,224 | 2021-05-10 |
What was the dosage of drug 'METHOTREXATE'? | Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid - no clear evidence of positive disease modifying effects.
BACKGROUND
All-trans retinoic acid (ATRA) is an acid derivative of vitamin A which is discussed as a promising candidate to ameliorate the disease course of multiple sclerosis (M... | UNK, QW | DrugDosageText | CC BY | 33966627 | 19,904,224 | 2021-05-10 |
What was the dosage of drug 'MITOXANTRONE HYDROCHLORIDE'? | Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid - no clear evidence of positive disease modifying effects.
BACKGROUND
All-trans retinoic acid (ATRA) is an acid derivative of vitamin A which is discussed as a promising candidate to ameliorate the disease course of multiple sclerosis (M... | 12 MILLIGRAM/SQ. METER, Q3MONTHS | DrugDosageText | CC BY | 33966627 | 19,904,224 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Progressive COVID-19-Associated Coagulopathy Despite Treatment with Therapeutic Anticoagulation and Thrombolysis.
BACKGROUND Coronavirus Disease 2019 (COVID-19) has been associated with a hypercoagulability state. Clinical presentation can range from asymptomatic to severe illness and mortality. Thrombotic complication... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC-ND | 33967265 | 19,666,111 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombosis'. | Progressive COVID-19-Associated Coagulopathy Despite Treatment with Therapeutic Anticoagulation and Thrombolysis.
BACKGROUND Coronavirus Disease 2019 (COVID-19) has been associated with a hypercoagulability state. Clinical presentation can range from asymptomatic to severe illness and mortality. Thrombotic complication... | ASPIRIN, CLOPIDOGREL BISULFATE | DrugsGivenReaction | CC BY-NC-ND | 33967265 | 19,666,111 | 2021-05-10 |
What is the weight of the patient? | Progressive COVID-19-Associated Coagulopathy Despite Treatment with Therapeutic Anticoagulation and Thrombolysis.
BACKGROUND Coronavirus Disease 2019 (COVID-19) has been associated with a hypercoagulability state. Clinical presentation can range from asymptomatic to severe illness and mortality. Thrombotic complication... | 82 kg. | Weight | CC BY-NC-ND | 33967265 | 19,666,111 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anxiety'. | Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study.
Bortezomib is a pivotal drug for the management of multiple myeloma. However, bortezomib is a neurotoxic anticancer drug responsible for chemotherapy-induced pe... | BORTEZOMIB | DrugsGivenReaction | CC BY | 33967771 | 19,281,497 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Depression'. | Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study.
Bortezomib is a pivotal drug for the management of multiple myeloma. However, bortezomib is a neurotoxic anticancer drug responsible for chemotherapy-induced pe... | BORTEZOMIB | DrugsGivenReaction | CC BY | 33967771 | 19,281,497 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'General physical health deterioration'. | Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study.
Bortezomib is a pivotal drug for the management of multiple myeloma. However, bortezomib is a neurotoxic anticancer drug responsible for chemotherapy-induced pe... | BORTEZOMIB | DrugsGivenReaction | CC BY | 33967771 | 19,281,497 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mental disorder'. | Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study.
Bortezomib is a pivotal drug for the management of multiple myeloma. However, bortezomib is a neurotoxic anticancer drug responsible for chemotherapy-induced pe... | BORTEZOMIB | DrugsGivenReaction | CC BY | 33967771 | 19,281,497 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study.
Bortezomib is a pivotal drug for the management of multiple myeloma. However, bortezomib is a neurotoxic anticancer drug responsible for chemotherapy-induced pe... | BORTEZOMIB | DrugsGivenReaction | CC BY | 33967771 | 19,281,497 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Autonomic nervous system imbalance'. | Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
In these times of COVID-19 pandemic, concern has been raised about the potential effects of SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B-cell de... | BENDAMUSTINE, COVID-19 CONVALESCENT PLASMA, FILGRASTIM, IMMUNE GLOBULIN NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33968017 | 19,475,952 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19 pneumonia'. | Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
In these times of COVID-19 pandemic, concern has been raised about the potential effects of SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B-cell de... | BENDAMUSTINE, COVID-19 CONVALESCENT PLASMA, FILGRASTIM, IMMUNE GLOBULIN NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33968017 | 19,475,952 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cognitive disorder'. | Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
In these times of COVID-19 pandemic, concern has been raised about the potential effects of SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B-cell de... | BENDAMUSTINE, COVID-19 CONVALESCENT PLASMA, FILGRASTIM, IMMUNE GLOBULIN NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33968017 | 19,475,952 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
In these times of COVID-19 pandemic, concern has been raised about the potential effects of SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B-cell de... | BENDAMUSTINE, COVID-19 CONVALESCENT PLASMA, FILGRASTIM, IMMUNE GLOBULIN NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33968017 | 19,475,952 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fall'. | Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
In these times of COVID-19 pandemic, concern has been raised about the potential effects of SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B-cell de... | BENDAMUSTINE, COVID-19 CONVALESCENT PLASMA, FILGRASTIM, IMMUNE GLOBULIN NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33968017 | 19,475,952 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
In these times of COVID-19 pandemic, concern has been raised about the potential effects of SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B-cell de... | BENDAMUSTINE, COVID-19 CONVALESCENT PLASMA, FILGRASTIM, IMMUNE GLOBULIN NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33968017 | 19,475,952 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect decreased'. | Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
In these times of COVID-19 pandemic, concern has been raised about the potential effects of SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B-cell de... | BENDAMUSTINE, COVID-19 CONVALESCENT PLASMA, FILGRASTIM, IMMUNE GLOBULIN NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33968017 | 19,475,952 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight decreased'. | Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
In these times of COVID-19 pandemic, concern has been raised about the potential effects of SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B-cell de... | BENDAMUSTINE, COVID-19 CONVALESCENT PLASMA, FILGRASTIM, IMMUNE GLOBULIN NOS, RITUXIMAB | DrugsGivenReaction | CC BY | 33968017 | 19,475,952 | 2021 |
What was the administration route of drug 'COVID-19 CONVALESCENT PLASMA'? | Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
In these times of COVID-19 pandemic, concern has been raised about the potential effects of SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B-cell de... | Other | DrugAdministrationRoute | CC BY | 33968017 | 19,475,952 | 2021 |
What was the administration route of drug 'IMMUNE GLOBULIN NOS'? | Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
In these times of COVID-19 pandemic, concern has been raised about the potential effects of SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B-cell de... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33968017 | 19,475,952 | 2021 |
What was the dosage of drug 'BENDAMUSTINE'? | Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
In these times of COVID-19 pandemic, concern has been raised about the potential effects of SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B-cell de... | RECEIVED 6 CYCLES | DrugDosageText | CC BY | 33968017 | 19,475,952 | 2021 |
What was the dosage of drug 'COVID-19 CONVALESCENT PLASMA'? | Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
In these times of COVID-19 pandemic, concern has been raised about the potential effects of SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B-cell de... | FOUR CYCLES | DrugDosageText | CC BY | 33968017 | 19,475,952 | 2021 |
What was the dosage of drug 'FILGRASTIM'? | Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
In these times of COVID-19 pandemic, concern has been raised about the potential effects of SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B-cell de... | 4 INJECTIONS: APRIL, 3, 9, 27 AND MAY 9, 2020 | DrugDosageText | CC BY | 33968017 | 19,475,952 | 2021 |
What was the dosage of drug 'IMMUNE GLOBULIN NOS'? | Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
In these times of COVID-19 pandemic, concern has been raised about the potential effects of SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B-cell de... | SINGLE DOSE OF 0.4 G/KG | DrugDosageText | CC BY | 33968017 | 19,475,952 | 2021 |
What was the dosage of drug 'RITUXIMAB'? | Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
In these times of COVID-19 pandemic, concern has been raised about the potential effects of SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B-cell de... | RECEIVED 6 CYCLES | DrugDosageText | CC BY | 33968017 | 19,475,952 | 2021 |
What was the outcome of reaction 'COVID-19 pneumonia'? | Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
In these times of COVID-19 pandemic, concern has been raised about the potential effects of SARS-CoV-2 infection on immunocompromised patients, particularly on those receiving B-cell de... | Recovered | ReactionOutcome | CC BY | 33968017 | 19,475,952 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arrhythmia'. | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33968450 | 19,322,873 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood lactic acid increased'. | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33968450 | 19,322,873 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QRS complex prolonged'. | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33968450 | 19,322,873 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QT prolonged'. | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33968450 | 19,322,873 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypokalaemia'. | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33968450 | 19,322,873 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional overdose'. | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33968450 | 19,322,873 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Liver function test abnormal'. | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33968450 | 19,322,873 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malaise'. | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33968450 | 19,322,873 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Poisoning'. | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33968450 | 19,322,873 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33968450 | 19,322,873 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33968450 | 19,322,873 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33968450 | 19,322,873 | 2021 |
What is the weight of the patient? | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | 60 kg. | Weight | CC BY | 33968450 | 19,322,873 | 2021 |
What was the dosage of drug 'HYDROXYCHLOROQUINE'? | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | INTENTIONALLY INGESTED 100 TABLETS OF 200MG ABOUT 12 HOURS EARLIER, EQUALING 20 G. | DrugDosageText | CC BY | 33968450 | 19,322,873 | 2021 |
What was the outcome of reaction 'Arrhythmia'? | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | Recovered | ReactionOutcome | CC BY | 33968450 | 19,322,873 | 2021 |
What was the outcome of reaction 'Blood lactic acid increased'? | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | Recovered | ReactionOutcome | CC BY | 33968450 | 19,322,873 | 2021 |
What was the outcome of reaction 'Electrocardiogram QRS complex prolonged'? | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | Recovered | ReactionOutcome | CC BY | 33968450 | 19,322,873 | 2021 |
What was the outcome of reaction 'Electrocardiogram QT prolonged'? | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | Recovered | ReactionOutcome | CC BY | 33968450 | 19,322,873 | 2021 |
What was the outcome of reaction 'Hypokalaemia'? | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | Recovered | ReactionOutcome | CC BY | 33968450 | 19,322,873 | 2021 |
What was the outcome of reaction 'Liver function test abnormal'? | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | Recovered | ReactionOutcome | CC BY | 33968450 | 19,322,873 | 2021 |
What was the outcome of reaction 'Malaise'? | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | Recovered | ReactionOutcome | CC BY | 33968450 | 19,322,873 | 2021 |
What was the outcome of reaction 'Renal impairment'? | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | Recovered | ReactionOutcome | CC BY | 33968450 | 19,322,873 | 2021 |
What was the outcome of reaction 'Vomiting'? | Nearly Fatal Hydroxychloroquine Overdose Successfully Treated with Midazolam, Propofol, Sodium Bicarbonate, Norepinephrine, and Intravenous Lipid Emulsion.
In the context of the current COVID-19 pandemic, there has been renewed interest in the drug hydroxychloroquine. However, clinicians should be aware of the dangers ... | Recovered | ReactionOutcome | CC BY | 33968450 | 19,322,873 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Fatal outcome of congenital aortopulmonary window with patent ductus arteriosus complicating pregnancy.
Aortopulmonary window (APW) is a rare congenital heart defect with abnormal communication between the ascending aorta and the pulmonary trunk with two separate semilunar valves. We present an autopsy case report wher... | SILDENAFIL | DrugsGivenReaction | CC BY | 33968832 | 20,020,324 | 2021-04-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal death'. | Fatal outcome of congenital aortopulmonary window with patent ductus arteriosus complicating pregnancy.
Aortopulmonary window (APW) is a rare congenital heart defect with abnormal communication between the ascending aorta and the pulmonary trunk with two separate semilunar valves. We present an autopsy case report wher... | SILDENAFIL | DrugsGivenReaction | CC BY | 33968832 | 20,020,324 | 2021-04-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Case Report: The Use of Intravenous SMOFlipid Infusion to Treat Severe Asparaginase-Induced Hypertriglyceridemia in Two Pediatric Acute Lymphoblastic Leukemia Patients.
Asparaginase-induced hypertriglyceridemia can have a spectrum of clinical presentations, from being asymptomatic to having life-threatening thrombosis ... | ASPARAGINASE, DAUNORUBICIN, DEXAMETHASONE, IMATINIB MESYLATE, METHOTREXATE, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY | 33968859 | 19,803,798 | 2021 |
What was the administration route of drug 'ASPARAGINASE'? | Case Report: The Use of Intravenous SMOFlipid Infusion to Treat Severe Asparaginase-Induced Hypertriglyceridemia in Two Pediatric Acute Lymphoblastic Leukemia Patients.
Asparaginase-induced hypertriglyceridemia can have a spectrum of clinical presentations, from being asymptomatic to having life-threatening thrombosis ... | Intramuscular | DrugAdministrationRoute | CC BY | 33968859 | 19,803,798 | 2021 |
What was the administration route of drug 'DAUNORUBICIN'? | Case Report: The Use of Intravenous SMOFlipid Infusion to Treat Severe Asparaginase-Induced Hypertriglyceridemia in Two Pediatric Acute Lymphoblastic Leukemia Patients.
Asparaginase-induced hypertriglyceridemia can have a spectrum of clinical presentations, from being asymptomatic to having life-threatening thrombosis ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33968859 | 19,803,798 | 2021 |
What was the administration route of drug 'DEXAMETHASONE'? | Case Report: The Use of Intravenous SMOFlipid Infusion to Treat Severe Asparaginase-Induced Hypertriglyceridemia in Two Pediatric Acute Lymphoblastic Leukemia Patients.
Asparaginase-induced hypertriglyceridemia can have a spectrum of clinical presentations, from being asymptomatic to having life-threatening thrombosis ... | Oral | DrugAdministrationRoute | CC BY | 33968859 | 19,803,798 | 2021 |
What was the administration route of drug 'IMATINIB MESYLATE'? | Case Report: The Use of Intravenous SMOFlipid Infusion to Treat Severe Asparaginase-Induced Hypertriglyceridemia in Two Pediatric Acute Lymphoblastic Leukemia Patients.
Asparaginase-induced hypertriglyceridemia can have a spectrum of clinical presentations, from being asymptomatic to having life-threatening thrombosis ... | Oral | DrugAdministrationRoute | CC BY | 33968859 | 19,803,798 | 2021 |
What was the administration route of drug 'METHOTREXATE'? | Case Report: The Use of Intravenous SMOFlipid Infusion to Treat Severe Asparaginase-Induced Hypertriglyceridemia in Two Pediatric Acute Lymphoblastic Leukemia Patients.
Asparaginase-induced hypertriglyceridemia can have a spectrum of clinical presentations, from being asymptomatic to having life-threatening thrombosis ... | Intrathecal | DrugAdministrationRoute | CC BY | 33968859 | 19,803,798 | 2021 |
What was the administration route of drug 'VINCRISTINE SULFATE'? | Case Report: The Use of Intravenous SMOFlipid Infusion to Treat Severe Asparaginase-Induced Hypertriglyceridemia in Two Pediatric Acute Lymphoblastic Leukemia Patients.
Asparaginase-induced hypertriglyceridemia can have a spectrum of clinical presentations, from being asymptomatic to having life-threatening thrombosis ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33968859 | 19,803,798 | 2021 |
What was the dosage of drug 'ASPARAGINASE'? | Case Report: The Use of Intravenous SMOFlipid Infusion to Treat Severe Asparaginase-Induced Hypertriglyceridemia in Two Pediatric Acute Lymphoblastic Leukemia Patients.
Asparaginase-induced hypertriglyceridemia can have a spectrum of clinical presentations, from being asymptomatic to having life-threatening thrombosis ... | 6000 IU/M2 EVERY OTHER DAY FOR 12 DOSES | DrugDosageText | CC BY | 33968859 | 19,803,798 | 2021 |
What was the dosage of drug 'DAUNORUBICIN'? | Case Report: The Use of Intravenous SMOFlipid Infusion to Treat Severe Asparaginase-Induced Hypertriglyceridemia in Two Pediatric Acute Lymphoblastic Leukemia Patients.
Asparaginase-induced hypertriglyceridemia can have a spectrum of clinical presentations, from being asymptomatic to having life-threatening thrombosis ... | 25MG/M2/DOSE WEEKLY X 4 WEEKS | DrugDosageText | CC BY | 33968859 | 19,803,798 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | Case Report: The Use of Intravenous SMOFlipid Infusion to Treat Severe Asparaginase-Induced Hypertriglyceridemia in Two Pediatric Acute Lymphoblastic Leukemia Patients.
Asparaginase-induced hypertriglyceridemia can have a spectrum of clinical presentations, from being asymptomatic to having life-threatening thrombosis ... | 6 MG/M2, DAILY | DrugDosageText | CC BY | 33968859 | 19,803,798 | 2021 |
What was the dosage of drug 'IMATINIB MESYLATE'? | Case Report: The Use of Intravenous SMOFlipid Infusion to Treat Severe Asparaginase-Induced Hypertriglyceridemia in Two Pediatric Acute Lymphoblastic Leukemia Patients.
Asparaginase-induced hypertriglyceridemia can have a spectrum of clinical presentations, from being asymptomatic to having life-threatening thrombosis ... | 300 MG/M2 DAILY | DrugDosageText | CC BY | 33968859 | 19,803,798 | 2021 |
What was the dosage of drug 'VINCRISTINE SULFATE'? | Case Report: The Use of Intravenous SMOFlipid Infusion to Treat Severe Asparaginase-Induced Hypertriglyceridemia in Two Pediatric Acute Lymphoblastic Leukemia Patients.
Asparaginase-induced hypertriglyceridemia can have a spectrum of clinical presentations, from being asymptomatic to having life-threatening thrombosis ... | 1.5MG/M2/DOSE WEEKLY FOR 5 WEEKS | DrugDosageText | CC BY | 33968859 | 19,803,798 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dizziness'. | Case Report: A Rare Presentation of NSAID-Induced Secondary Membranous Nephropathy in a Pediatric Patient.
Background: Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults, but it is responsible for <5% of nephrotic syndrome cases in children. MN has primary and secondary forms. Secondary MN is... | IBUPROFEN, LISINOPRIL, PREDNISONE | DrugsGivenReaction | CC BY | 33968861 | 19,373,801 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Case Report: A Rare Presentation of NSAID-Induced Secondary Membranous Nephropathy in a Pediatric Patient.
Background: Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults, but it is responsible for <5% of nephrotic syndrome cases in children. MN has primary and secondary forms. Secondary MN is... | IBUPROFEN, LISINOPRIL, PREDNISONE | DrugsGivenReaction | CC BY | 33968861 | 19,373,801 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Case Report: A Rare Presentation of NSAID-Induced Secondary Membranous Nephropathy in a Pediatric Patient.
Background: Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults, but it is responsible for <5% of nephrotic syndrome cases in children. MN has primary and secondary forms. Secondary MN is... | IBUPROFEN | DrugsGivenReaction | CC BY | 33968861 | 19,307,326 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperlipidaemia'. | Case Report: A Rare Presentation of NSAID-Induced Secondary Membranous Nephropathy in a Pediatric Patient.
Background: Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults, but it is responsible for <5% of nephrotic syndrome cases in children. MN has primary and secondary forms. Secondary MN is... | IBUPROFEN | DrugsGivenReaction | CC BY | 33968861 | 19,307,326 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoalbuminaemia'. | Case Report: A Rare Presentation of NSAID-Induced Secondary Membranous Nephropathy in a Pediatric Patient.
Background: Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults, but it is responsible for <5% of nephrotic syndrome cases in children. MN has primary and secondary forms. Secondary MN is... | IBUPROFEN | DrugsGivenReaction | CC BY | 33968861 | 19,307,326 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyponatraemia'. | Case Report: A Rare Presentation of NSAID-Induced Secondary Membranous Nephropathy in a Pediatric Patient.
Background: Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults, but it is responsible for <5% of nephrotic syndrome cases in children. MN has primary and secondary forms. Secondary MN is... | IBUPROFEN | DrugsGivenReaction | CC BY | 33968861 | 19,307,326 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedema peripheral'. | Case Report: A Rare Presentation of NSAID-Induced Secondary Membranous Nephropathy in a Pediatric Patient.
Background: Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults, but it is responsible for <5% of nephrotic syndrome cases in children. MN has primary and secondary forms. Secondary MN is... | IBUPROFEN | DrugsGivenReaction | CC BY | 33968861 | 19,307,326 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peripheral swelling'. | Case Report: A Rare Presentation of NSAID-Induced Secondary Membranous Nephropathy in a Pediatric Patient.
Background: Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults, but it is responsible for <5% of nephrotic syndrome cases in children. MN has primary and secondary forms. Secondary MN is... | IBUPROFEN | DrugsGivenReaction | CC BY | 33968861 | 19,307,326 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Proteinuria'. | Case Report: A Rare Presentation of NSAID-Induced Secondary Membranous Nephropathy in a Pediatric Patient.
Background: Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults, but it is responsible for <5% of nephrotic syndrome cases in children. MN has primary and secondary forms. Secondary MN is... | IBUPROFEN | DrugsGivenReaction | CC BY | 33968861 | 19,307,326 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight increased'. | Case Report: A Rare Presentation of NSAID-Induced Secondary Membranous Nephropathy in a Pediatric Patient.
Background: Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults, but it is responsible for <5% of nephrotic syndrome cases in children. MN has primary and secondary forms. Secondary MN is... | IBUPROFEN | DrugsGivenReaction | CC BY | 33968861 | 19,307,326 | 2021 |
What is the weight of the patient? | Case Report: A Rare Presentation of NSAID-Induced Secondary Membranous Nephropathy in a Pediatric Patient.
Background: Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults, but it is responsible for <5% of nephrotic syndrome cases in children. MN has primary and secondary forms. Secondary MN is... | 68.3 kg. | Weight | CC BY | 33968861 | 19,381,124 | 2021 |
What was the administration route of drug 'LISINOPRIL'? | Case Report: A Rare Presentation of NSAID-Induced Secondary Membranous Nephropathy in a Pediatric Patient.
Background: Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults, but it is responsible for <5% of nephrotic syndrome cases in children. MN has primary and secondary forms. Secondary MN is... | Oral | DrugAdministrationRoute | CC BY | 33968861 | 19,392,791 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.